Delivery Order SPE2DB22D3016-SPE2DB24FBGB9

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $36K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $40,202.40 to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4,565,161,303 units of the ROTARIX vaccine oral syringe, 1.5 mL. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical...
The Defense Logistics Agency (DLA) awarded a $36,887.14 firm-fixed price delivery order to Amerisourcebergen Drug Corp., a subsidiary of Amerisourcebergen Corporation, for the supply of ROTARIX vaccine oral syringes. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
The Defense Logistics Agency (DLA) awarded a $3,335.35 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTARIX vaccine oral syringe 1.5ML. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,999.00 firm fixed-price delivery order is for the procurement of ROTARIX VACCINE ORAL SYRINGE 1.5ML. The contract has a completion date of December 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $24,566.16 contract is for the procurement of ROTARIX vaccine oral syringes, 1.5 mL, with a period of performance through December 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTARIX vaccine oral syringe 1.5ML. The $2,929.56 firm fixed-price contract has an ultimate completion date of October 22, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
The Defense Logistics Agency (DLA) awarded a $10,985.85 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTARIX vaccine oral syringes (1.5 ml). This contract, which has an ultimate completion date of October 28, 2024, supports military treatment facilities, veterans' healthcare programs, and other federal medical institutions. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,476.68 firm fixed-price delivery order is for the supply of ROTARIX vaccine oral syringes, 1.5 mL, to support military healthcare programs. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,510.56 firm fixed-price delivery order is for the ROTARIX vaccine oral syringes in 1.5 ML size. The contract has an ultimate completion date of May 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $10,268.58 for the provision of ROTARIX vaccine oral syringes. The award has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor, and this order is fulfilled under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp valued at up to...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBGB9
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $36,109.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of the ROTARIX VACCINE ORAL SYRINGE 1.5ML. This delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion by September 6, 2024. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to provide essential medications, vaccines, and medical supplies to various federal agencies and healthcare programs.

Generated 12/5/24, 10:23 AM